Michael Graves - 27 Oct 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Director
Signature
/s/ Scott Tarriff, Attorney-in-Fact
Issuer symbol
EGRX
Transactions as of
27 Oct 2023
Net transactions value
+$46,238
Form type
4
Filing time
31 Oct 2023, 17:41:24 UTC
Previous filing
09 Mar 2023
Next filing
22 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Options Exercise $46,238 +9,360 +936% $4.94 10,360 27 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EGRX Stock Option (right to buy) Options Exercise $0 -9,360 -100% $0.000000* 0 27 Oct 2023 Common Stock 9,360 $4.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.